Catching the missing million: Experiences in enhancing TB & DR-TB detection by providing upfront xpert MTB/RIF testing for people living with HIV in India

PLoS ONE

Volumn 10, Issue 2, 2015, Pages

  Raizada, Neeraj ^a   Sachdeva, Kuldeep Singh ^b   Sreenivas, Achuthan ^c   Kulsange, Shubhangi ^a   Gupta, Radhey Shyam ^b   Thakur, Rahul ^a   Dewan, Puneet ^c   Boehme, Catharina ^d   Paramsivan, Chinnambedu Nainarappan ^a  

^a Foundation for Innovative New Diagnostics   (India)

^b Central TB Division   (India)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

^d FOUNDATION FOR INNOVATIVE NEW DIAGNOSTICS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

RIFAMPICIN;

ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC EQUIPMENT; DRUG RESISTANT TUBERCULOSIS; FEMALE; GEOGRAPHIC DISTRIBUTION; HEALTH CARE FACILITY; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INDIA; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PROSPECTIVE STUDY; RAPID TEST; SPUTUM SMEAR; TREATMENT FAILURE; TUBERCULOSIS; TURNAROUND TIME; CLINICAL TRIAL; HIV INFECTIONS; MULTICENTER STUDY; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY;

DRUG RESISTANCE, BACTERIAL; FEMALE; HIV INFECTIONS; HUMANS; INDIA; MALE; RIFAMPIN; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY;

EID: 84922720440     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0116721     Document Type: Article

References (35)

1. UNAIDS report on the global AIDS epidemic (2013) Global report, Page no 4; Available: http://www. unaids.org/en/media/unaids/contentassets/documents/epidemiology/2013/gr2013/UNAIDS-Global- Report-2013-en.pdf
2. TB HIV Facts 2012-2013, Available: http://www.who.int/hiv/topics/tb/tbhiv-facts-2013/en/. Accessed 2014 May 20.
3. Dewan P, Gupta D, Williams B G, Thakur R, Bachani D, et al. (2010) National estimate of HIV sero prevalence among tuberculosis patients in India. International Journal of Tuberculosis and Lung Disease; 14(2): 247-9. Available: http://tbcindia.nic.in/pdfs/National%20estimate%20of%20HIV% 20seroprevalence%20among%20tuberculosis%20patients%20in%20India.pdf PMID: 20074420
4. World Health Organization, Global Tuberculosis report (2013), page no 9, Available: http://apps.who. int/iris/bitstream/10665/91355/1/9789241564656-eng.pdf?ua=1
5. WHO policy on collaborative TB/HIV activities (2012) Guidelines for national programmes and other stakeholders (2012), Available: http://whqlibdoc.who.int/publications/2012/9789241503006-eng.pdf
6. Agarwal S, Roy D, Chauhan LS. Book Chapter 16 TB-HIV Co-infection: A Lethal Combination, Available: http://tbcindia.nic.in/pdfs/Tuberculosis%20Control%20in%20India16.pdf
7. Hargreaves N, Scano F (2003) Guidelines for Implementing Collaborative TB and HIV Programme Activities, World Health Organization, Geneva, 2003;7,9,11,13-15. Available: http://www.popline.org/ node/241599 PMID: 25057689
8. Cain KP, McCarthy KD, Heilig CM, Monkongdee P, Tasaneeyapan T, et. al. (2010) An algorithm for tuberculosis screening and diagnosis in people with HIV. N Engl J Med 2010; 362:707-16, Available: http://www.ncbi.nlm.nih.gov/pubmed/20181972 doi: 10.1056/NEJMoa0907488 PMID: 20181972
9. Centres for Disease Control and Prevention, Morbidity and Mortality weekly report (MMWR Weekly) / Vol.61/ No.26 /, July 06, 2012. Available: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6126a3. htm?s-cid = mm6126a3-w
10. World Health Organization (2009) Pathways to better diagnostics for tuberculosis: a blueprint for the development of TB diagnostics by the new diagnostics working group of the Stop TB Partnership.
11. Barnard M, Gey vann Pittius NC, van Helden PD, Bosman M, Coetzee G, et al. (2012) The Diagnostic Performance of the GenoType MTBDRplus Version 2 Line Probe Assay Is Equivalent to That of the Xpert MTB/RIF Assay, J. Clin. Microbiol. November 2012 vol. 50 no. 11 3712-3716, Available: http:// jcm.asm.org/content/50/11/3712.full doi: 10.1128/JCM.01958-12 PMID: 22972826
12. World health Organization Policy update (2013) Automated Real-time Nucleic Acid Amplification Technology for Rapid and Simultaneous Detection of Tuberculosis and Rifampicin Resistance: Xpert MTB/ RIF assay for the diagnosis of pulmonary and extra-pulmonary TB in adults and children. Policy Update WHO/HTM/TB/2013.16. Available: http://apps.who.int/iris/bitstream/10665/112472/1/ 9789241506335-eng.pdf?ua=1
13. Central TB Division Ministry of Health and Family Welfare, Managing the RNTCP in your area-A training course (Module 1-4). Available: http://tbcindia.nic.in/pdfs/Module%201%20to%204.zip
14. World Health Organization, Geneva (2013) Definitions and reporting framework for tuberculosis-2013 revision. S.n. p. 3. Available: http://apps.who.int/iris/bitstream/10665/79199/1/9789241505345-eng. pdf
15. Central TB Division Ministry of Health and Family Welfare, New Delhi, India, Revised National TB Control Programme (2012) Guidelines on Programmatic Management of Drug Resitant TB (PMDT) in India. Available: http://tbcindia.nic.in/pdfs/Guidelines%20for%20PMDT%20in%20India%20-%20May% 202012.pdf
16. Theron G, Peter J, van Zyl-Smit R, Mishra H, Streicher E, et al. (2011) Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting, Am J Respir Crit Care Med. 2011 Jul 1; 184(1):132-40. Epub 2011 Apr 14. Available: http://www.ncbi.nlm.nih.gov/ pubmed/21493734 doi: 10.1164/rccm.201101-0056OC PMID: 21493734
17. Balcha TT, Sturegard E, Winqvist N, Skogmar S, Reepalu A, et al. (2014) Intensified Tuberculosis Case-Finding in HIV-Positive Adults Managed at Ethiopian Health Centers: Diagnostic Yield of Xpert MTB/RIF Compared with Smear Microscopy and Liquid Culture. PLoS ONE 9(1): e85478. Available: http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0085478 doi: 10.1371/ journal.pone.0085478 PMID: 24465572
18. Anastasis D, Pillai G, Rambiritch V and Abdool Karim SS (1997) A retrospective study of human immunodeficiency virus infection and drug-resistant tuberculosis, Int J Tuberc Lung Dis. 1997 Jun; 1(3):220-4, Available: http://www.ncbi.nlm.nih.gov/pubmed/9432367 PMID: 9432367
19. Rasaki SO, AJibola AA, Musa SA, Moradeyo AK, LO O, et al. (2014) Rifampicin Resistant Tuberculosis in a Secondary Health Institution in Nigeria, West Africa. J Infect Dis Ther 2: 139. Available: http:// esciencecentral.org/journals/rifampicin-resistant-tuberculosis-in-a-secondary-health-institution-innigeria- west-africa-2332-0877.1000139.php?aid=26243 doi: 10.4172/2332-0877.1000139
20. Cox H, Hughes J, Moyo S, Daniels J, Cutsem G, et al. (2014) Reduced treatment delays for drug-resistant TB/HIV co-infected patients with decentralized care and rapid Xpert MTB/RIF test in Khayelitsha, South Africa. 20th International AIDS Conference, abstract MOAB0203, Melbourne, 2014. Available: http://pag.aids2014.org/Abstracts.aspx?SID=1142&AID=8215
21. Lukoye D, Adatu F, Musisi K, Kasule GW, Were W, et al. (2013) Anti-Tuberculosis Drug Resistance among New and Previously Treated Sputum Smear-Positive Tuberculosis Patients in Uganda: Results of the First National Survey. PLoS ONE 8(8): e70763. Available: http://www.plosone.org/article/info% 3Adoi%2F10.1371%2Fjournal.pone.0070763 doi: 10.1371/journal.pone.0070763 PMID: 23936467
22. Brewer TF, Choi HW, Seas C, Krapp F, Zamudio C, et al. (2011) Self-Reported Risks for Multiple-Drug Resistance among New Tuberculosis Cases: Implications for Drug Susceptibility Screening and Treatment. PLoS ONE 6(10): e25861. Available: http://www.plosone.org/article/info%3Adoi%2F10.1371% 2Fjournal.pone.0025861 doi: 10.1371/journal.pone.0025861 PMID: 22022459
23. Coovadia YM, Mahomed S, Pillay M, Werner L, Mlisana K, et.al (2013) Rifampicin Mono-Resistance in Mycobacterium tuberculosis in KwaZulu-Natal, South Africa: A Significant Phenomenon in a High Prevalence TB-HIV Region. PLoS ONE 8(11): e77712. Available: http://www.plosone.org/article/info% 3Adoi%2F10.1371%2Fjournal.pone.0077712 doi: 10.1371/journal.pone.0077712 PMID: 24223122
24. Osman M, Simpson J, Caldwell J, Bosman M, Nicolb MP, et al. (2014) GeneXpert MTB/RIF Version G4 for Identification of Rifampin- Resistant Tuberculosis in a Programmatic Setting, J. Clin. Microbiol. February 2014 vol. 52 no. 2 635-637 Available: http://jcm.asm.org/content/52/2/635.full doi: 10.1128/JCM. 02517-13 PMID: 24478501
25. Kwak N, Choi SM, Lee J, Park YS, Lee C-H, et al. (2013) Diagnostic Accuracy and Turnaround Time of the Xpert MTB/RIF Assay in Routine Clinical Practice. PLoS ONE 8(10): e77456. Available: http:// www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0077456 doi: 10.1371/journal. pone.0077456 PMID: 24204834
26. Loannidis P, Papaventsis D, Karabela S, Nikolaou S, Panagi M, et al (2011) Cepheid GeneXpert MTB/ RIF Assay for Mycobacterium tuberculosis Detection and Rifampin Resistance Identification in Patients with Substantial Clinical Indications of Tuberculosis and Smear-Negative Microscopy Results; Available: http://jcm.asm.org/content/49/8/3068.long
27. Raizada N, Sachdeva KS, Sreenivas A, Vadera B, Gupta RS, et al. (2014) Feasibility of Decentralised Deployment of Xpert MTB/RIF Test at Lower Level of Health System in India. PLoS ONE 9(2): e89301. Available: http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0089301 doi: 10. 1371/journal.pone.0089301 PMID: 24586675
28. Zeka A Z, Tasbakan S and Cavusoglu C, (2011) Evaluation of the GeneXpert MTB/RIF Assay for Rapid Diagnosis of Tuberculosis and Detection of Rifampin Resistance in Pulmonary and Extrapulmonary Specimens, J. Clin. Microbiol. December 2011 vol. 49 no. 12 4138-4141, Available: http://jcm.asm. org/content/49/12/4138.full doi: 10.1128/JCM.05434-11 PMID: 21956978
29. Kim CH, Woo H, Hyun IG, Kim C, Choi JH, et. al. (2014) A comparison between the efficiency of the Xpert MTB/RIF assay and nested PCR in identifying Mycobacterium tuberculosis during routine clinical practice Journal of Thoracic Medicine, Vol 6, No 6 (June 2014) Available: http://www.jthoracdis.com/ article/view/2534/html
30. Corbett EL, Watt CJ, Walker N, Maher D, Williams BG, et al. (2003) The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med. 2003; 163:1009-1021. PMID: 12742798
31. Gandhi N, Shah N, Andrews J, Vella V, Moll A, et al (2010) HIV Co-infection in Multidrug- and Extensively Drug-Resistant Tuberculosis Results in High Early Mortality, American Journal of Respiratory and Critical Care Medicine, Vol. 181, No. 1 (2010), pp. 80-86. Available: http://www.atsjournals.org/ doi/abs/10.1164/rccm.200907-0989OC#.U9CNwPmSwod doi: 10.1164/rccm.200907-0989OC PMID: 19833824
32. ODonnell MR, Padayatchi N, Kvasnovsky C, Werner L, Master I, et. al (2013) Treatment Outcomes for Extensively Drug-Resistant Tuberculosis and HIV Co-infection, Volume 19, Number 3-March 2013, Available: http://wwwnc.cdc.gov/eid/article/19/3/12-0998-article
33. Central TB Division Ministry of Health and Family Welfare, Revised National Tuberculosis Program Annual status report-2014 (2014) Available: http://www.tbcindia.nic.in/pdfs/TB%20INDIA%202014.pdf. Accessed 2014 August 16.
34. Nwokeukwu HI, Inya-Agha DU and Nwogu KC, (2013) Treatment outcome of Tuberculosis and HIV Co-infection at a Tertiary Health Facility in Southeastern Nigeria Journal of Community Medicine and Primary Health Care. 25 (1) 58-64, Available: http://www.ajol.info/index.php/jcmphc/article/viewFile/ 95517/84858
35. Vijay S, Kumar P, Chauhan LS, Narayan Rao SV, Vaidyanathan P, et al (2011) Treatment Outcome and Mortality at One and Half Year Follow-Up of HIV Infected TB Patients Under TB Control Programme in a District of South India. PLoS ONE 6(7): e21008. doi: 10.1371/journal.pone.0021008 PMID: 21814542